|
1
|
Taniguchi H, Ito S, Ueda T, Morioka Y,
Kayukawa N, Ueno A, Nakagawa H, Fujihara A, Ushijima S, Kanazawa M,
et al: CNPY2 promoted the proliferation of renal cell carcinoma
cells and increased the expression of TP53. Biochem Biophys Res
Commun. 485:267–271. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hirata H, Hinoda Y, Nakajima K, Kawamoto
K, Kikuno N, Ueno K, Yamamura S, Zaman MS, Khatri G, Chen Y, et al:
Wnt antagonist DKK1 acts as a tumor suppressor gene that induces
apoptosis and inhibits proliferation in human renal cell carcinoma.
Int J Cancer. 128:1793–1803. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hsu HH, Chen MC, Day CH, Lin YM, Li SY, Tu
CC, Padma VV, Shih HN, Kuo WW and Huang CY: Thymoquinone suppresses
migration of LoVo human colon cancer cells by reducing
prostaglandin E2 induced COX-2 activation. World J Gastroenterol.
23:1171–1179. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hossen MJ, Yang WS, Kim D, Aravinthan A,
Kim JH and Cho JY: Thymoquinone: An IRAK1 inhibitor with in vivo
and in vitro anti-inflammatory activities. Sci Rep. 7:429952017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cobourne-Duval MK, Taka E, Mendonca P,
Bauer D and Soliman KF: The antioxidant effects of thymoquinone in
activated BV-2 murine microglial cells. Neurochem Res.
41:3227–3238. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ke X, Zhao Y, Lu X, Wang Z, Liu Y, Ren M,
Lu G, Zhang D, Sun Z, Xu Z, et al: TQ inhibits hepatocellular
carcinoma growth in vitro and in vivo via repression of Notch
signaling. Oncotarget. 6:32610–32621. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Taha MM, Sheikh BY, Salim LZ, Mohan S,
Khan A, Kamalidehghan B, Ahmadipour F and Abdelwahab SI:
Thymoquinone induces apoptosis and increase ROS in ovarian cancer
cell line. Cell Mol Biol (Noisy-le-grand). 62:97–101.
2016.PubMed/NCBI
|
|
8
|
Yang J, Kuang XR, Lv PT and Yan XX:
Thymoquinone inhibits proliferation and invasion of human
nonsmall-cell lung cancer cells via ERK pathway. Tumour Biol.
36:259–269. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wilson AJ, Saskowski J, Barham W, Yull F
and Khabele D: Thymoquinone enhances cisplatin-response through
direct tumor effects in a syngeneic mouse model of ovarian cancer.
J Ovarian Res. 8:462015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Park EJ, Chauhan AK, Min KJ, Park DC and
Kwon TK: Thymoquinone induces apoptosis through downregulation of
c-FLIP and Bcl-2 in renal carcinoma Caki cells. Oncol Rep.
36:2261–2267. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jeghers H, Mckusick VA and Katz KH:
Generalized intestinal polyposis and melanin spots of the oral
mucosa, lips and digits; a syndrome of diagnostic significance. N
Engl J Med. 241:1031–1036. 1949. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
LKB1 and AMPK maintain epithelial cell
polarity under energetic stress. J Cell Biol. 203:3732013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dahmani R, Just PA, Delay A, Canal F,
Finzi L, Prip-Buus C, Lambert M, Sujobert P, Buchet-Poyau K, Miller
E, et al: A novel LKB1 isoform enhances AMPK metabolic activity and
displays oncogenic properties. Oncogene. 34:2337–2346. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kan JY, Yen MC, Wang JY, Wu DC, Chiu YJ,
Ho YW and Kuo PL: Nesfatin-1/Nucleobindin-2 enhances cell
migration, invasion, and epithelial-mesenchymal transition via
LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer. Oncotarget.
7:31336–31349. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Taliaferro-Smith L, Nagalingam A, Zhong D,
Zhou W, Saxena NK and Sharma D: LKB1 is required for
adiponectin-mediated modulation of AMPK-S6K axis and inhibition of
migration and invasion of breast cancer cells. Oncogene.
28:2621–2633. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Marcus AI and Zhou W: LKB1 regulated
pathways in lung cancer invasion and metastasis. J Thorac Oncol.
5:1883–1886. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Teng S, Zhang Y, Zhang W, Zhang X,
Xu K, Yao H, Yao J, Wang H, Liang X and Hu Z: TROP2 promotes
proliferation, migration and metastasis of gallbladder cancer cells
by regulating PI3K/AKT pathway and inducing EMT. Oncotarget.
8:47052–47063. 2017.PubMed/NCBI
|
|
18
|
Li N, Huang D, Lu N and Luo L: Role of the
LKB1/AMPK pathway in tumor invasion and metastasis of cancer cells
(Review). Oncol Rep. 34:2821–2826. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ahmad I, Muneer KM, Tamimi IA, Chang ME,
Ata MO and Yusuf N: Thymoquinone suppresses metastasis of melanoma
cells by inhibition of NLRP3 inflammasome. Toxicol Appl Pharmacol.
270:70–76. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kolli-Bouhafs K, Boukhari A, Abusnina A,
Velot E, Gies JP, Lugnier C and Rondé P: Thymoquinone reduces
migration and invasion of human glioblastoma cells associated with
FAK, MMP-2 and MMP-9 down-regulation. Invest New Drugs.
30:2121–2131. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhou Y, Zhu Y, Fan X, Zhang C, Wang Y,
Zhang L, Zhang H, Wen T, Zhang K, Huo X, et al: NID1, a new
regulator of EMT required for metastasis and chemoresistance of
ovarian cancer cells. Oncotarget. 8:33110–33121. 2017.PubMed/NCBI
|
|
22
|
Zhao S, Sun H, Jiang W, Mi Y, Zhang D, Wen
Y, Cheng D, Tang H, Wu S, Yu Y, et al: miR-4775 promotes colorectal
cancer invasion and metastasis via the Smad7/TGFβ-mediated
epithelial to mesenchymal transition. Mol Cancer. 16:122017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Khan MA, Tania M, Wei C, Mei Z, Fu S,
Cheng J, Xu J and Fu J: Thymoquinone inhibits cancer metastasis by
downregulating TWIST1 expression to reduce epithelial to
mesenchymal transition. Oncotarget. 6:19580–19591. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Weng J, Zhang H, Wang C, Liang J, Chen G,
Li W, Tang H and Hou J: miR-373-3p targets DKK1 to promote
EMT-induced metastasis via the Wnt/β-catenin pathway in tongue
squamous cell carcinoma. Biomed Res Int. 2017:60109262017.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chen J, Zhang H, Chen Y, Qiao G, Jiang W,
Ni P, Liu X and Ma L: miR-598 inhibits metastasis in colorectal
cancer by suppressing JAG1/Notch2 pathway stimulating EMT. Exp Cell
Res. 352:104–112. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wei S, Wang L, Zhang L, Li B, Li Z, Zhang
Q, Wang J, Chen L, Sun G, Li Q, et al: ZNF143 enhances metastasis
of gastric cancer by promoting the process of EMT through PI3K/AKT
signaling pathway. Tumour Biol. 37:12813–12821. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li J, Liu J, Li P, Mao X, Li W, Yang J and
Liu P: Loss of LKB1 disrupts breast epithelial cell polarity and
promotes breast cancer metastasis and invasion. J Exp Clin Cancer
Res. 33:702014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang X, Wang P, Gao Q and Tao X:
Exogenous activation of LKB1/AMPK signaling induces G(1) arrest in
cells with endogenous LKB1 expression. Mol Med Rep. 9:1019–1024.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Luo L, Huang W, Tao R, Hu N, Xiao ZX and
Luo Z: ATM and LKB1 dependent activation of AMPK sensitizes cancer
cells to etoposide-induced apoptosis. Cancer Lett. 328:114–119.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Goodwin JM, Svensson RU, Lou HJ, Winslow
MM, Turk BE and Shaw RJ: An AMPK-independent signaling pathway
downstream of the LKB1 tumor suppressor controls Snail1 and
metastatic potential. Mol Cell. 55:436–450. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Roy BC, Kohno T, Iwakawa R, Moriguchi T,
Kiyono T, Morishita K, Sanchez-Cespedes M, Akiyama T and Yokota J:
Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of
human lung cancer cells. Lung Cancer. 70:136–145. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kopsiaftis S, Sullivan KL, Garg I, Taylor
JR III and Claffey KP: AMPKα2 regulates bladder cancer growth
through SKP2-mediated degradation of p27. Mol Cancer Res.
14:1182–1194. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhan P, Zhao S, Yan H, Yin C, Xiao Y, Wang
Y, Ni R, Chen W, Wei G and Zhang P: α-enolase promotes
tumorigenesis and metastasis via regulating AMPK/mTOR pathway in
colorectal cancer. Mol Carcinog. 56:1427–1437. 2017. View Article : Google Scholar : PubMed/NCBI
|
